Bionaturis Group, in the 14th Annual World Preclinical Congress in Boston

BBD BioPhenix–Biobide, subsidiary of Bionaturis Group, is attending this week the 14th Annual World Preclinical Congress, a prestigious international meeting hold in June 10-12th in Boston (USA). The R&D Management Director of the Company based in San Sebastian, Arantza Muriana, is attending this relevant forum, devoted to preclinical research and the challenges and opportunities in early drug discovery and development. This meeting brings together outstanding companies and scientists in the world to deal with the latest topics in pharmaceutical Biotechnology, which means a great chance to show the board services portfolio of BBD BioPhenix-Biobide and Bionaturis Group to future customers and partners.

For further information about the event, please click here

The presence of Bionaturis Group in this forum is included in its international expansion with effective presence in the American continent. Besides this forum, BBD BioPhenix-Biobide and Bionaturis will attend shortly other international events, such as the Bio Convention, also in the USA.

About Bionaturis Group

Bionaturis Group is a Spanish biopharmaceutical Company, listing in Madrid on the Alternative Equity Market (MAB) since 2012, with a core business focus in the investigation, development and production of biotechnological solutions in order to improve the global health access for persons and animals. Bionaturis has production facilities in Jerez (Cadiz) and San Sebastian (Basque Country) as well as commercial agreements in China and Latam.

June 10th, 2015|Blog english, congress|Comments Off on Bionaturis Group, in the 14th Annual World Preclinical Congress in Boston

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.